NeoCore Technology Co., Ltd. (TPEX:4131)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
35.30
-0.30 (-0.84%)
Apr 29, 2026, 1:30 PM CST
1.00%
Market Cap 1.40B
Revenue (ttm) 244.66M
Net Income (ttm) -30.87M
Shares Out 39.79M
EPS (ttm) -0.78
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 58,005
Average Volume 94,419
Open 35.80
Previous Close 35.60
Day's Range 34.85 - 35.95
52-Week Range 30.10 - 42.45
Beta -0.23
RSI 44.91
Earnings Date May 12, 2026

About NeoCore Technology

NeoCore Technology Co., Ltd. designs, manufactures, and sells biochips and rapid nucleic acid hybridization devices. The company’s products include food safety examination systems, human diagnosis arrays systems, agriculture examination systems, food examination arrays systems, and laboratory instruments, as well as DNA kits. It also offers laboratory planning, design, and other services. In addition, the company engages in the wholesale and retail of contact lenses. The company was formerly known as DR. Chip Biotechnology Incorporation and cha... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1987
Employees 44
Stock Exchange Taipei Exchange
Ticker Symbol 4131
Full Company Profile

Financial Performance

In 2025, NeoCore Technology's revenue was 244.66 million, an increase of 297.52% compared to the previous year's 61.55 million. Losses were -30.87 million, -35.87% less than in 2024.

Financial Statements

News

There is no news available yet.